FBB
WST icon

Fulton Breakefield Broenniman’s West Pharmaceutical WST Stock Holding History

Fulton Breakefield Broenniman’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
+635
New +$194K 0.01% 188
2025
Q1 		– Sell
-1,170
Closed -$383K – 200
2024
Q4 		$383K Buy
+1,170
New +$368K 0.03% 135

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fulton Breakefield Broenniman's WST Position: Q2 2026 in Review

Fulton Breakefield Broenniman opened a new position in West Pharmaceutical (WST) in Q2 2026: 635 shares worth $228K. The stake represents 0.01% of the portfolio and ranks #188 among its holdings. This is a return to the name: Fulton Breakefield Broenniman previously reported a position in WST as recently as Q4 2024.

Fulton Breakefield Broenniman first reported a position in WST in Q4 2024 and has held it in 2 quarters since. The position peaked at $383K in Q4 2024. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Fulton Breakefield Broenniman held 635 shares of West Pharmaceutical worth $228K as of Q2 2026.
  • West Pharmaceutical was a new Fulton Breakefield Broenniman position in Q2 2026.
  • West Pharmaceutical made up 0.01% of Fulton Breakefield Broenniman's portfolio in Q2 2026, its #188 holding.
  • Fulton Breakefield Broenniman first reported a position in West Pharmaceutical in Q4 2024 and has held it in 2 quarters since.
  • Fulton Breakefield Broenniman's West Pharmaceutical position peaked at $383K in Q4 2024.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.